Standard Chem & Pharm CO., LTD.

Taiwan Stock Exchange 1720.TW

Standard Chem & Pharm CO., LTD. Cash and Short-Term Investments for the year ending December 31, 2023: USD 74.12 M

Standard Chem & Pharm CO., LTD. Cash and Short-Term Investments is USD 74.12 M for the year ending December 31, 2023, a -12.57% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Standard Chem & Pharm CO., LTD. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 84.78 M, a -21.38% change year over year.
Standard Chem & Pharm CO., LTD. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 107.83 M, a 104.76% change year over year.
Standard Chem & Pharm CO., LTD. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 52.66 M, a -6.91% change year over year.
Standard Chem & Pharm CO., LTD. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 56.57 M, a 19.26% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Taiwan Stock Exchange: 1720.TW

Standard Chem & Pharm CO., LTD.

CEO	Mr. Tzu-Ting Fan
IPO Date	Jan. 4, 2000
Location	Taiwan
Headquarters	No. 6-20, Tuku
Employees	1,130
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Standard Chem & Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.

Key trends

Past 5 years